Skip to main navigation Skip to search Skip to main content

Gefitinib/Afatinib therapy for Head and Neck Squamous Cell Carcinomas in Fanconi anemia.

Project Details

StatusFinished
Effective start/end date1/04/19 → 1/09/22

Funding

  • The Fanconi Anemia Research Foundation Inc.: €137,091.00